MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galigniana, M. D.
Right arrow Articles by Assreuy, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galigniana, M. D.
Right arrow Articles by Assreuy, J.

Vol. 55, Issue 2, 317-323, February 1999

Inhibition of Glucocorticoid Receptor Binding by Nitric Oxide

Mario D. Galigniana, Graciela Piwien-Pilipuk, and Jamil Assreuy

Departments of Pharmacology (M.D.G.) and Physiology (G.P.P.), The University of Michigan Medical School, Ann Arbor, Michigan; and Department of Pharmacology, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil (J.A.)

Septic shock is a dangerous condition with high mortality rates. In sepsis, the inducible form of nitric oxide (NO) synthase is induced, releasing high amounts of NO. Glucocorticoids have potent anti-inflammatory properties and are very effective in inhibiting the induction of this enzyme if administered before the shock onset. It is known that glucocorticoid receptor (GR) has critical cysteine residues for steroid binding in its hormone-binding and DNA-binding domains. It has also been reported that NO reacts with ---SH groups, forming S-nitrosothiols. Therefore, we examined the potential effect of NO on the ligand-binding ability of GR. NO donors (S-nitroso-acetyl-DL-penicillamine, S-nitroso-DL-penicillamine, or S-nitroso-glutathione) decreased, in a time- and dose-dependent manner, the binding of [3H]triamcinolone to immunoprecipitated GR from mouse L929 fibroblasts. The nonnitrosylated parent molecules, N-acetyl-DL-penicillamine, and reduced gluthatione were without effect. Scatchard plots revealed that the number of ligand binding sites and Kd were reduced (50%) by NO donors. Western blot analysis ruled out the possibility that dissociation of GR/heat shock protein 90 heterocomplex or decrease in GR protein would account for the inhibitory effect of NO. Decreased ligand binding to GR was found when NO donors were incubated with intact fibroblasts. Incubation with NO donors also decreased the steroid-induced reduction in [3H]uridine incorporation into RNA. All of these NO effects were inhibited by the thiol-protecting agent dithiothreitol. Therefore, S-nitrosylation of critical ---SH groups in GR by NO with consequent decreases in binding and affinity may be the mechanisms which explain the failure of glucocorticoids to exert their anti-inflammatory effects in septic shock.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I. Rahman and I. M. Adcock
Oxidative stress and redox regulation of lung inflammation in COPD.
Eur. Respir. J., July 1, 2006; 28(1): 219 - 242.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. J. Barnes
Corticosteroid effects on cell signalling
Eur. Respir. J., February 1, 2006; 27(2): 413 - 426.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. J. Barnes, I. M. Adcock, and K. Ito
Histone acetylation and deacetylation: importance in inflammatory lung diseases
Eur. Respir. J., March 1, 2005; 25(3): 552 - 563.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N.C. Thomson, R. Chaudhuri, and E. Livingston
Asthma and cigarette smoking
Eur. Respir. J., November 1, 2004; 24(5): 822 - 833.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
I. C. Chikanza and D. L. Kozaci
Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives
Rheumatology, November 1, 2004; 43(11): 1337 - 1345.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Jeong, K. Y. Lee, D. Shin, H. Chung, S. H. Jeon, and R. H. Seong
Nitric Oxide Inhibits Glucocorticoid-induced Apoptosis of Thymocytes by Repressing the SRG3 Expression
J. Biol. Chem., August 13, 2004; 279(33): 34373 - 34379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Cheron, J. Peltier, J. Perez, A. Bellocq, B. Fouqueray, and L. Baud
15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Glucocorticoid Binding and Signaling in Macrophages through a Peroxisome Proliferator-Activated Receptor {gamma}-Independent Process
J. Immunol., June 15, 2004; 172(12): 7677 - 7683.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. L. M. Ricciardolo, A. Di Stefano, N. C. Thomson, R. Chaudhuri, and E. Livingston
Corticosteroid Resistance in Smokers with Asthma
Am. J. Respir. Crit. Care Med., June 1, 2004; 169(11): 1252 - 1253.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Martinez-Ruiz and S. Lamas
S-nitrosylation: a potential new paradigm in signal transduction
Cardiovasc Res, April 1, 2004; 62(1): 43 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Paul-Clark, F. Roviezzo, R. J. Flower, G. Cirino, P. D. Soldato, I. M. Adcock, and M. Perretti
Glucocorticoid Receptor Nitration Leads to Enhanced Anti-Inflammatory Effects of Novel Steroid Ligands
J. Immunol., September 15, 2003; 171(6): 3245 - 3252.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. De Bosscher, W. Vanden Berghe, and G. Haegeman
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression
Endocr. Rev., August 1, 2003; 24(4): 488 - 522.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Marchetti, M. C. Morale, J. Brouwer, C. Tirolo, N. Testa, S. Caniglia, N. Barden, S. Amor, P. A. Smith, and C. D. Dijkstra
Exposure to a Dysfunctional Glucocorticoid Receptor from Early Embryonic Life Programs the Resistance to Experimental Autoimmune Encephalomyelitis Via Nitric Oxide-Induced Immunosuppression
J. Immunol., June 1, 2002; 168(11): 5848 - 5859.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. KRAFT, Q. HAMID, G. P. CHROUSOS, R. J. MARTIN, and D. Y. M. LEUNG
Decreased Steroid Responsiveness at Night in Nocturnal Asthma . Is the Macrophage Responsible?
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1219 - 1225.
[Abstract] [Full Text]


Home page
FASEB J.Home page
H. E. MARSHALL, K. MERCHANT, and J. S. STAMLER
Nitrosation and oxidation in the regulation of gene expression
FASEB J, October 1, 2000; 14(13): 1889 - 1900.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
Y. Amrani, A. L. Lazaar, and R. A. Panettieri Jr.
Up-Regulation of ICAM-1 by Cytokines in Human Tracheal Smooth Muscle Cells Involves an NF-{kappa}B-Dependent Signaling Pathway That Is Only Partially Sensitive to Dexamethasone
J. Immunol., August 15, 1999; 163(4): 2128 - 2134.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics